Cyclosporin and Organ Specific Toxicity: Clinical Aspects, Pharmacogenetics and Perspectives
Journal:
Current Clinical Pharmacology
Volume:
3
Page:
166-173
Author(s):
Alberto Magnasco, Andrea Rossi, Paolo Catarsi, Rosanna Gusmano, Fabrizio Ginevri, Francesco Perfumo and Gian Marco Ghiggeri
Therapeutic Implications of Beta-Adrenergic Receptor Pharmacodynamic Properties
Journal:
Current Clinical Pharmacology
Volume:
3
Page:
174-184
Author(s):
Carlos A. Taira, Andrea Carranza, Marcos Mayer, Carla Di Verniero, Javier A.W. Opezzo and Christian Hocht
The Interaction Between Burn Injury and Vitamin D Metabolism and Consequences for the Patient
Journal:
Current Clinical Pharmacology
Volume:
3
Page:
204-210
Author(s):
Gordon L. Klein
Iron Involvement in Multiple Signaling Pathways of Atherosclerosis: A Revisited Hypothesis
Journal:
Current Medicinal Chemistry
Volume:
15
Page:
2157-2172
Author(s):
Xi-Ming Yuan and Wei Li
Genes, Environment, and Interactions in Prevention of Type 2 Diabetes: A Focus on Physical Activity and Lifestyle Changes
Journal:
Current Molecular Medicine
Volume:
8
Page:
519-532
Author(s):
Lu Qi, Frank B. Hu and Gang Hu
Cardiovascular Disease in Patients with Diabetic Nephropathy
Journal:
Current Molecular Medicine
Volume:
8
Page:
533-543
Author(s):
Yoshimasa Aso
Enzymes as Target Antigens of Liver-Specific Autoimmunity: The Case of Cytochromes P450s
Journal:
Current Medicinal Chemistry
Volume:
15
Page:
2285-2292
Author(s):
D. P. Bogdanos and G. N. Dalekos
Soluble CD40L and its Role in Essential Hypertension: Diagnostic and Therapeutic Implications
Journal:
Cardiovascular & Hematological Disorders-Drug Targets
Volume:
8
Page:
194-202
Author(s):
Patrizia Ferroni and Fiorella Guadagni
Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 (LOX-1), a Relevant Target for Diabetic Vasculopathy?
Journal:
Cardiovascular & Hematological Disorders-Drug Targets
Volume:
8
Page:
203-211
Author(s):
Genevieve Renier
A More Accurate Approach to Molecular Genetics Analysis in Vascular Disease
Journal:
Cardiovascular & Hematological Disorders-Drug Targets
Volume:
8
Page:
212-227
Author(s):
Jose Ignacio Lao Villadoniga